Toxicity-over-time analysis of anti-EGFR-based maintenance versus stop&go in left-sided, RAS/BRAF wild-type metastatic colorectal cancer.

Raimondi A, Tinè G, Boige V, Ballhausen A, Gourgou S, Stahler A, Randon G, Manca P, Brument E, Alig AHS, Morano F, Prisciandaro M, Ambrosini M, Fazio R, Zhu Y, Miceli R, Bouche O, Modest DP, Pietrantonio F.

Open source

DOI
10.1093/jnci/djag160
Published
2026-05-22
Container
J Natl Cancer Inst
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/jnci/djag160,
  title = {Toxicity-over-time analysis of anti-EGFR-based maintenance versus stop\&go in left-sided, RAS/BRAF wild-type metastatic colorectal cancer.},
  author = {Raimondi A and  Tinè G and  Boige V and  Ballhausen A and  Gourgou S and  Stahler A and  Randon G and  Manca P and  Brument E and  Alig AHS and  Morano F and  Prisciandaro M and  Ambrosini M and  Fazio R and  Zhu Y and  Miceli R and  Bouche O and  Modest DP and  Pietrantonio F.},
  year = {2026},
  journal = {J Natl Cancer Inst},
  doi = {10.1093/jnci/djag160},
  url = {https://doi.org/10.1093/jnci/djag160}
}

RIS

TY  - JOUR
TI  - Toxicity-over-time analysis of anti-EGFR-based maintenance versus stop&go in left-sided, RAS/BRAF wild-type metastatic colorectal cancer.
AU  - Raimondi A
AU  -  Tinè G
AU  -  Boige V
AU  -  Ballhausen A
AU  -  Gourgou S
AU  -  Stahler A
AU  -  Randon G
AU  -  Manca P
AU  -  Brument E
AU  -  Alig AHS
AU  -  Morano F
AU  -  Prisciandaro M
AU  -  Ambrosini M
AU  -  Fazio R
AU  -  Zhu Y
AU  -  Miceli R
AU  -  Bouche O
AU  -  Modest DP
AU  -  Pietrantonio F.
PY  - 2026
JO  - J Natl Cancer Inst
DO  - 10.1093/jnci/djag160
UR  - https://doi.org/10.1093/jnci/djag160
ER  - 

APA

A, R., G, T., V, B., A, B., S, G., A, S., G, R., P, M., E, B., AHS, A., F, M., M, P., M, A., R, F., Y, Z., R, M., O, B., DP, M., & F., P. (2026). Toxicity-over-time analysis of anti-EGFR-based maintenance versus stop&go in left-sided, RAS/BRAF wild-type metastatic colorectal cancer.. J Natl Cancer Inst. https://doi.org/10.1093/jnci/djag160

Source records